What is Evereden?
Founded in 2018 and headquartered in New York, Evereden has carved out a distinct niche by bridging the gap between clinical-grade dermatology and clean, non-toxic skincare for mothers and children. By focusing on high-efficacy formulations—ranging from specialized diaper creams to advanced stretch mark lotions—the company addresses the specific physiological needs of its target demographic. Evereden operates at the intersection of wellness and retail, leveraging a direct-to-consumer model that emphasizes transparency, safety, and scientific rigor. Its market position is defined by a commitment to rigorous testing standards, often exceeding industry norms to ensure product integrity for sensitive skin types.
How much funding has Evereden raised?
Evereden has raised a total of $32M across 1 funding round:
Series C
$32M
Series C (2021): $32M with participation from GSR Ventures
Key Investors in Evereden
GSR Ventures
A prominent venture capital firm specializing in early-to-growth stage investments, with a strong focus on technology-driven consumer and healthcare innovations.
Undisclosed Investor
Undisclosed investor participating in the funding round.
Undisclosed Investor
Undisclosed investor participating in the funding round.
What's next for Evereden?
With the successful closure of this Series C financing, Evereden is well-positioned to accelerate its expansion strategy. The capital will likely be deployed toward scaling its supply chain, enhancing research and development capabilities for new product lines, and deepening its penetration into international markets. As the company transitions from a high-growth startup to a more mature enterprise-level entity, the focus will shift toward optimizing customer acquisition costs and strengthening brand loyalty through community-driven engagement. The strategic backing provided by its investors serves as a catalyst for long-term sustainability, enabling the firm to maintain its competitive edge in the rapidly evolving wellness and personal care sector.
See full Evereden company page
